Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 13,932

Document Document Title
WO/2013/115378
The present invention relates to: a method for producing a ruthenium catalyst, wherein ruthenium supported by a metal oxide is pretreated with an aldehyde compound, a phosphorus compound and a lower alcohol compound; and a method for pro...  
WO/2013/110313
Compounds of formula (I) are provided wherein R1 represents H, CN and CF3; R2 represents 1-naphthyl, 3,5-dichlorophenyl, 4-(4-fluorophenylthio)phenyl or phenyl substituted with one or more substituent selected from halogen, methoxy, cyan...  
WO/2013/107904
The invention relates to an alkoxycarbonylation process for the preparation of an optionally substituted alkanoic acid ester comprising reacting: (a) an optionally substituted alkene or a mixture thereof; (b) a source of a group 8-10 met...  
WO/2013/107947
The present invention describes a method for pretreating lignocellulosic biomass comprising: a) a step of acid hydrolysis of the biomass with an acid solution resulting in a liquid fraction and a solid fraction, b) a step of separating t...  
WO/2013/109477
Processes are disclosed for the conversion of a carbohydrate source to hexamethylenediamine (HMDA) and to intermediates useful for the production of hexamethylenediamine and other industrial chemicals. HMDA is produced by direct reductio...  
WO/2013/107948
The present invention relates to a method for preprocessing lignocellulosic biomass, include: a) a step for the acid hydrolysis of the biomass using an acid solution so as to obtain a liquid fraction and a solid fraction; a step of separ...  
WO/2013/105118
Disclosed herein is a novel route of synthesis of syn azide epoxide of formu 5, which is used as a common intermdeiate for asymmetric synthesis of HIV protease inhibitors such as Amprenavir, Fosamprenavir, Saquinavir and formal synthesis...  
WO/2013/105708
The present invention relates to a method for preparing α-metylene lactone comprising the steps of: (A) preparing an enolate intermediate by reacting lactone with alkyl formate under conditions in which an alcoxide base exists; and (B) ...  
WO/2013/105118
Disclosed herein is a novel route of synthesis of syn azide epoxide of formu 5, which is used as a common intermdeiate for asymmetric synthesis of HIV protease inhibitors such as Amprenavir, Fosamprenavir, Saquinavir and formal synthesis...  
WO/2013/104257
Disclosed in the present invention are polycyclic derivatives as represented by general formula (I), the preparation method thereof, pharmaceutical compositions containing the derivatives and uses thereof as therapeutical agents, especia...  
WO/2013/106136
Hydroxymethylfurfural is made from an aqueous hexose sugar solution, especially from a high fructose corn syrup product. By rapidly heating the sugar solution to the elevated temperatures involved as well as rapidly cooling the resultant...  
WO/2013/106137
A process is described wherein a feed of a six-carbon carbohydrate-containing material or of a furanic dehydration product from a six-carbon carbohydrate-containing material or of a combination of these is supplied to a reactor in a cont...  
WO/2013/102935
The present invention disclosed herein is a novel commercially feasible, one pot synthesis of library of 3-substituted phthalides of formula I via CuCN mediated oxidative cyclization in high yield. Formula I  
WO/2013/102911
The present invention relates to a process for chemical conversion of cellulose isolated from aromatic spent biomass to hydroxymethyl furfural using an eco-friendly and economical liquids system with recoverable and reusable solid Indion...  
WO/2013/102935
The present invention disclosed herein is a novel commercially feasible, one pot synthesis of library of 3-substituted phthalides of formula I via CuCN mediated oxidative cyclization in high yield. Formula I  
WO/2013/100467
The present invention relates to a compound for an organic optoelectric device, an organic light-emitting diode including the same, and a display device including the organic light-emitting diode, wherein the compound for the organic opt...  
WO/2013/101977
Disclosed herein are processes comprising contacting isosorbide with hydrogen in the presence of a first hydrogenation catalyst to form a first product mixture comprising tetrahydrofuran-2, 5-dimethanol. The processes can further compris...  
WO/2013/102007
Furfural is produced in one step at both high yield and high conversion from a feedstock comprising solid biomass and/or insoluble polysaccharide, in a high boiling, water-miscible solvent containing a soluble acid catalyst, and water. F...  
WO/2013/100464
The present invention relates to a compound for an organic optoelectronic element, to an organic light-emitting element comprising same and to a display device comprising the organic light-emitting element; and provided is a compound for...  
WO/2013/101970
Disclosed are processes comprising contacting an aqueous reaction mixture having an initial pH between about 3 and about 6 and comprising levoglucosenone with a catalyst, and heating the reaction mixture to form a product mixture compris...  
WO/2013/097773
The invention provides novel ethylene derivatives represented by Formula I, which may be used as selective estrogen receptor modulators (SERMs) and useful in the prophylaxis and/or treatment of estrogen-dependent conditions or conditions.  
WO/2013/096998
The present invention refers to a process for production of a mix¬ ture comprising 2,4-furandicarboxyiic acid (2,4-FDCA) and 2,5 furandicar- boxyiic acid (2,5-FDCA) through the disproportionation route, using as base compounds oxidation...  
WO/2013/102015
Furfural is produced by contacting a feedstock solution containing C5 sugar and/or C6 sugar with a solid acid catalyst using reactive distillation. Both high yield and high conversion are obtained, without production of insoluble char in...  
WO/2013/097042
Disclosed is a compound of formula 1, as shown below, where R1, R2, R3, R4, R5, R6 and R7 are as described herein. Also, disclosed is a process for the preparation of compounds of formula 1, and intermediates used therein. The compound o...  
WO/2013/099553
Provided is a novel 2-fluorophenylpropionic acid derivative which has excellent anti-inflammatory/analgesic effects, while avoiding side effects such as gastrointestinal disorders, namely a 2-fluorophenylpropionic acid derivative represe...  
WO/2013/099998
The present invention is a radiation-sensitive resin composition which contains [A] a polymer that has a structural unit represented by formula (1) and [B] an acid generator. In formula (1), R2 represents a hydrogen atom or a monovalent ...  
WO/2013/102027
Furfural is produced by mixing an aqueous feedstock solution containing C5 sugar and/or C6 sugar with a heated high boiling, water-miscible solvent, such as sulfolane, and a solid acid catalyst. Furfural product and water can be distille...  
WO/2013/097752
Disclosed are natural products as retinoic acid receptor (RARs) excitomotors and the uses thereof. The marine natural products Luffariellolide and Manoalide are specific excitomotors of retinoic acid receptors (RARs), able to inhibit the...  
WO/2013/102000
Furfural is produced by contacting an aqueous feedstock solution containing C5 sugar and/or C6 sugar using a soluble acid catalyst with reactive distillation. Both high yield and high conversion are obtained in the reaction vessel. Degra...  
WO/2013/098416
The present invention relates to the use of compounds for the treatment or prevention of pain in mammals, in particularly in human beings, and also to a process for preparing these compounds.  
WO/2013/101999
Furfural is produced by mixing an aqueous feedstock solution containing C5 sugar and/or C6 sugar with a heated, high boiling, water-miscible solvent, such as sulfolane, and a soluble acid catalyst. Furfural product and water are distille...  
WO/2013/102002
Processes for making furfural and 5-hydroxymethylfurfural from sugars are provided. The processes can be carried out using a batch process or a continuous mode of operation. An aqueous sugar solution is pressurized with CO2, thereby prod...  
WO/2013/098416
The present invention relates to the use of compounds for the treatment or prevention of pain in mammals, in particularly in human beings, and also to a process for preparing these compounds.  
WO/2013/093322
The invention relates to a method for oxidizing 5-hydroxymethyl furaldehyde, including at least one step of oxidation in the presence of an organic acid, a nitroxyl radical, an oxygen source, and an oxygen transfer agent.  
WO/2013/091062
The present invention comprises aldimine-derived compounds, pharmaceutical compositions containing such compounds and pharmaceutically acceptable excipients, beside the use thereof for treating fungal infections of medicinal and/or veter...  
WO/2013/093508
A class of compounds having general formula (I) has been identified. These compounds function as inhibitors of the Wnt pathway. Compounds of formula (I) are suitable for the treatment and/or prevention of any condition or disease in whic...  
WO/2013/094676
A hydroxymethylfurfural derivative represented by general formula (A). In the formula, R is selected from the group consisting of formula (I), (II) HOOCCH2COCO-, (III) HOOCCH2CH2COCO-, and (IV) a hydrogen atom.  
WO/2013/093508
Wnt pathway inhibitors A class of compounds having general formula (I) has been identified. These compounds function as inhibitors of the Wnt pathway. Compounds of formula (I) are suitable for the treatment and/or prevention of any condi...  
WO/2013/094646
Provided are: a novel bis(hydroxyamide)-based acid dianhydride exhibiting high transparency and superior solubility in organic solvents; a method for producing same; and a polyimide obtained therefrom. The acid dianhydride compound is re...  
WO/2013/093528
The invention relates to a process for the preparation of travoprost of formula(I), comprising that, the compound of formula (II), is stereoselectively reduced, the resulting compound of formula (III), is if desired crystallized, the lac...  
WO/2013/087614
A process for preparing 5-hydroxymethylfurfural (HMF), characterized in that a) solutions (called starting solution hereinafter) comprising one or more saccharides and an organic solvent having a boiling point greater than 200°C (at sta...  
WO/2013/086634
Discloses is a process for preparation of a compound of formula 7, or a derivative thereof, wherein PG1 is an alcohol protecting group. Also, disclosed are intermediates and processes for their preparation. The compound of formula 7 can ...  
WO/2013/087523
A process for preparing solutions which comprise 5-hydroxymethylfurfural (HMF) and have reduced content of starting materials from the HMF synthesis or a reduced content of by-products of the HMF synthesis (called product solution herein...  
WO/2013/087765
The present invention relates to the manufacture of compounds of general formula I or III including nitrile functions. Specifically, the invention relates to the manufacture of compounds including nitrile functions from compounds which i...  
WO/2013/090041
A method to produce levulinic acid (LA) and gamma- valerolactone (GVL) from biomass-derived cellulose or lignocellulose by selective extraction of LA using GVL and optionally converting the LA so isolated into GVL, with no purifications ...  
WO/2013/087954
The present invention relates to the use of a compound of formula (I) for treating Alzheimer's disease, and in particular relates to a pharmaceutical composition that comprises said compound and to the use thereof for the treatment of Al...  
WO/2013/088972
Provided is a compound represented by general formula (1). (1) In general formula (1), R1 is either a protecting group for a hydroxyl group or a hydrogen atom. R2 is either a methyl group or an ethyl group.  
WO/2013/087613
A process for preparing 5-hydroxymethylfurfural (HMF), characterized in that a) solutions (called starting solution hereinafter) comprising a hexose and an organic solvent having a boiling point greater than 200°C (at standard pressure)...  
WO/2013/085243
The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device containing the same. Using the organic electroluminescent compounds of the present invention, it is possible to manufac...  
WO/2013/083225
The invention relates to the use of specific glucuronolactone derivates as self-tanning substances, as tanning intensifiers for dihydroxyacetone or for a mixture of self-tanning substances containing dihydroxyacetone for modulation of th...  

Matches 151 - 200 out of 13,932